This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 19:22, 21 September 2011 (Updating {{chembox}} (no changed fields - added verified revid - updated 'ChEMBL_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref') per Chem/Drugbox validation (report errors or [[user talk:CheMoBot|bug). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 19:22, 21 September 2011 by CheMoBot (talk | contribs) (Updating {{chembox}} (no changed fields - added verified revid - updated 'ChEMBL_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref') per Chem/Drugbox validation (report errors or [[user talk:CheMoBot|bug)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)Names | |
---|---|
IUPAC name 2-(3-chloro-2-methylanilino)pyridine-3-carboxylic acid | |
Other names Clonixic acid; CBA 93626 | |
Identifiers | |
CAS Number | |
3D model (JSmol) | |
ECHA InfoCard | 100.037.921 |
KEGG | |
PubChem CID | |
CompTox Dashboard (EPA) | |
SMILES
| |
Properties | |
Chemical formula | C13H11ClN2O2 |
Molar mass | 262.69 g·mol |
Pharmacology | |
Routes of administration |
per os |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Y verify (what is ?) Infobox references |
Clonixin is a non-steroidal anti-inflammatory drug. It also has analgesic, antipyretic, and platelet-inhibitory actions. It is used primarily in the treatment of chronic arthritic conditions and certain soft tissue disorders associated with pain and inflammation.
References
- The Journal of Clinical Pharmacology. "Clonixin: A Clinical Evaluation of a New Oral Analgesic". Retrieved 2010-06-16.
This drug article relating to the musculoskeletal system is a stub. You can help Misplaced Pages by expanding it. |